Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Licenses Liquid Biopsy Tech to University of Melbourne

NEW YORK (GenomeWeb) – Transgenomic announced today that it has granted a license to the University of Melbourne to use its multiplexed ICE-COLD PCR (MX-ICP) technology for certain research and clinical applications.

The deal, which follows a collaboration between the parties to clinically validate the DNA amplification technology, specifically provides the university with an exclusive license to Transgenomic's MX-ICP-enabled EGFR liquid biopsy cancer assays in Australia.

According to the company, the four tests detect specific actionable mutations associated with sensitivity or resistance to targeted drugs used for colorectal and non-small cell lung cancer in sample types including plasma. They will be available for both research use and diagnostic applications through the university's National Association of Testing Authorities certified laboratory.

Transgenomic will sell the tests to the University of Melbourne and will also receive royalties. The partners have also agreed to jointly provide biomarker identification services to biopharmaceutical companies.

"The agreement has the added benefit of providing us with the opportunity for additional validation of our MX-ICP technology and our new liquid biopsy diagnostic assays in partnership with a top-tier cancer institution," Transgenomic President and CEO Paul Kinnon said in a statement. "This is the first of what we expect to be many licenses worldwide for our MX-ICP technology."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.